Table 1.
Staging, incidence and outcomes in penile cancer
| Stagea | 2012 incidence in US | 2012 deaths in US | ∼5-year survival (%) |
|---|---|---|---|
| 0 (Tis or Ta, N0M0) | NA | NA | 100 |
| 1 (T1aN0M0) | NA | NA | 90 |
| 2 (T1b–T3N0M0) | NA | NA | 50 |
| 3 (T1–T3N1–N2M0) | NA | NA | 30 |
| 4 (any T4, any N3 or M1) | NA | NA | 5 |
| All stages | 1570 [1] | 310 | NA |
aAdapted from American Joint Committee on Cancer (AJCC) Staging Manual, seventh edition (2010) published by Springer, New York, Inc.
Tis: carcinoma in situ; Ta: noninvasive verrucous carcinoma; T1a: tumor invades subepithelial connective tissue without lymphovascular invasion (LVI) and is not high grade 3–4; T1b: tumor invades subepithelial connective tissue with LVI or is grade 3–4; T2: tumor invades corpus spongiosum or cavernosum; T3: tumor invades urethra; T4: tumor invades other adjacent structures; N1: mobile unilateral inguinal lymph node; N2: mobile multiple or bilateral inguinal lymph nodes; N3: palpable fixed inguinal nodal mass or pelvic lymphadenopathy; M1: distant metastasis; NA: not available.